Skip to main content

Novartis news in 2026: 25 dated events

The latest Novartis event on this page is dated Nov 12, 2026. globenewswire.com reported: New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Dated events
25
Last 90 days
20
Latest
Nov 12, 2026

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

News · latest 10

Latest Novartis news

  1. In development
    New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)Novartis announced 52-week results from the Phase III RemIND program evaluating Rhapsido (remibrutinib) in chronic inducible urticaria.
  2. Recognition
    Novartis ranks first place in 2026 Access to Medicine IndexNovartis ranked first place in the 2026 Access to Medicine Index published by the Access to Medicine Foundation.
  3. Partnership ended
  4. In development
    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)Novartis initiated a second Phase 2 clinical study evaluating the VAV1-directed molecular glue degrader MRT-6160 (DDY391) in patients with active moderate to severe psoriatic arthritis.
  5. Revenue
  6. In development
    Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrenceNovartis announced positive six-year follow-up results from the Phase III NATALEE trial evaluating Kisqali plus endocrine therapy for stage II and III HR+/HER2- early breast cancer.
  7. Partnership
  8. Revenue
    3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
  9. In development
    Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
  10. News

Showing 10 of 25 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns Novartis news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Novartis news

What is the latest news on Novartis?
The newest event on this page is dated Nov 12, 2026. globenewswire.com reported: New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU). This page lists 25 dated events for Novartis, each with a source link.
What is going on with Novartis?
The 10 latest events on this page cover in development (4), recognition (1), partnership ended (1), revenue (2), partnership (1) and news (1). The newest: Nov 12, 2026: New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU) (globenewswire.com).
Is Novartis laying off employees?
1 layoff event was reported for Novartis. The latest: Sep 2, 2026: Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned (bazonline.ch). See the Novartis layoffs page for the dated list.

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →